A new analgesia regimen after (adeno) tonsillectomy in children: a pilot study
Objective The objective was to ascertain the efficacy of a new analgesic regimen introduced in children undergoing (adeno)tonsillectomy in view of the ban on codeine use in children <12 years by the European Medicines Agency (EMA) and UK Medicines and Healthcare Products Regulatory Agency (MHRA)....
Saved in:
Published in | Clinical otolaryngology Vol. 41; no. 6; pp. 660 - 665 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.12.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
The objective was to ascertain the efficacy of a new analgesic regimen introduced in children undergoing (adeno)tonsillectomy in view of the ban on codeine use in children <12 years by the European Medicines Agency (EMA) and UK Medicines and Healthcare Products Regulatory Agency (MHRA).
Design
Prospective pilot study at a paediatric tertiary referral centre.
Materials and methods
A total of 176 children undergoing (adeno) tonsillectomy over a 5‐month period (Sept 2013‐Jan 2014) were included in the study. Data were prospectively collected on analgesia used peri‐operatively and patients were discharged on regular paracetamol and ibuprofen for 7 days and three doses of oral morphine sulphate solution to be used on days 3, 4 and 5. Pain scores were recorded on days 1–10 post‐operatively using the Wong Baker Faces Pain Rating scale.
Results
The pain scores were significantly better (P‐value < 0.0001) in children who were compliant with morphine (n = 93) than those who were not (n = 32). We also found that children who were compliant with morphine were less likely to seek help out of hours (P‐value < 0.001).
Conclusions
Oral morphine sulphate solution provides a reasonable alternative to codeine, albeit one should bear in mind that parental concerns and adverse effects of the drug were seen in a minority of patients (n = 11) and anaesthetists were reluctant to prescribe the drug in cases of severe OSA or associated central apnoeas (n = 7). |
---|---|
Bibliography: | ArticleID:COA12579 istex:281CA80A3F702DB2045AFAAFAE19E50B888391E0 ark:/67375/WNG-L7BLTQ5C-L ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 1749-4478 1749-4486 |
DOI: | 10.1111/coa.12579 |